Imaging software developer Median Technologies has been selected to provide imaging services for two new clinical studies in oncology and has also signed an extension related to an existing contract.
The contracts total 1.53 million euros, which will be broken out accordingly:
- A 1.06 million euro phase I study (solid tumor cancers)
- A 198,000 euro phase II study (prostate cancer)
- A 268,000 euro phase I/II contract extension (solid tumor cancers)
